Search Main Menu Main Content
  • Change contrast :
Retour à l'accueil du site de la HAS
logo HAS
icone
  • HAS profile
    • Mission
    • Organisational Structure
    • Ethics, transparency and management of conflicts of interest
  • International relations and projects
  • Publications
  1. root
  2. AMELUZ (acide 5-aminolévulinique (chlorhydrate de l'))
  • icone plus
  • My account

    • Email alert Subscription
    • Newsletter Subscription
    • My search
    Refresh
    Please fill in your email address to retrieve your email alerts subscriptions.
    New subscription
    Please fill in your email address to retrieve your newsletter subscriptions.

    You do not have a saved search

    Mon Compte
  • No element in selection

    Favoris
  • Établissements de santé
  • Contact Abonnez-vous aux actualités
Listen Listen
Add to my selection
  • History
  • Technical informations
Share
Share on
Facebook share - facebook.com - new window
Tweeter share - Partager sur Twitter - twitter.com - new window
LinkedIn share - linkedin.com - new window
Print

AMELUZ (acide 5-aminolévulinique (chlorhydrate de l'))

Medicine - Posted on Nov 28 2024
Active substance (DCI)
  • acide 5-aminolévulinique (chlorhydrate de l')
history (3)
  • 10/23/24

    AMELUZ (5-aminolevulinic acid) - Basal cell carcinomas

    Summary of opinion Favourable opinion for reimbursement only in the treatment of superficial basal cell carcinoma unsuitable...
    CAV :
    54321
    icône flèche
  • 10/23/24

    AMELUZ (5-aminolevulinic acid) - Actinic keratoses

    Summary of opinion Favourable opinion for reimbursement in the “treatment of actinic keratosis of mild to moderate severity ...
    CAV :
    54321
    icône flèche
  • 2/3/16

    AMELUZ (5-aminolaevulinic acid), photodynamic therapy

    No clinical benefit demonstrated over METVIXIA in the treatment of actinic keratosis on the face and scalp. AMELUZ has Marke...
    CAV :
    54321
    icône flèche
Technical information
ATC code
  • L01XD04
Manufacturer
BIOFRONTERA PHARMA GMBH
Presentation

AMELUZ 78 mg/g, gel (code CIS : 65115071)
1 tube aluminium de 2 g (CIP : 34009 300 013 8 7)

All our publications
    Drug therapy Skin and connective tissue cancers Skin and connective tissue diseases

Follow us :

  • Twitter (nouvelle fenêtre)
  • Facebook (nouvelle fenêtre)
  • Youtube (nouvelle fenêtre)
  • LinkedIn (nouvelle fenêtre)
Haute Autorité de Santé
Advancing quality in the fields of health and social care services
  • Eunetha.eu
  • Pasq.eu
  • All our publications by topic and type
  • Opinions on medicines
  • Opinions on medical devices
  • INAHTA briefs
  • Français
  • English
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
QPcFXyatf5v7gGz8